Alberto Bossi, MD, highlights the crucial role of #brachytherapy as a boost for high-grade prostate cancer cases, complementing active surveillance for lower-grade diseases. He stresses its effectiveness in extending survival for at-risk patients, emphasizing its combination with external beam radiotherapy. Additionally, he discusses its utility in salvage settings and for patients with previous pelvic irradiation. His insights underscore the evolving landscape of prostate cancer treatment. Discover more on https://www.elekta.com/products/brachytherapy/prostate/radiation-oncologists
